Cell-free DNA testing for 22q11.2 deletion syndrome: Appraising the viability, effectiveness and appropriateness of screening

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 2, 2016, Pages 137-141

  Hui, L ^a,b,c  

^a MERCY HOSPITAL FOR WOMEN   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CHROMOSOME 22; CHROMOSOME DELETION; DIGEORGE SYNDROME; HUMAN; SYNDROME;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; DNA; HUMANS; SYNDROME;

EID: 84957705240     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15845     Document Type: Note

References (33)

1. Gross SJ, Stosic M, McDonald-McGinn DM, Bassett AS, Norvez A, Dhamankar R, Kobara K, Kirkizlar E, Zimmermann B, Wayham N, Babiarz JE, Ryan A, Jinnett KN, Demko Z, Benn P., Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol 2016; 47: 177-183.
2. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, Oliver K, Rava RP, Sehnert AJ,; CARE Study Group. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370: 799-808.
3. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, Tomlinson MW, Pereira L, Spitz JL, Hollemon D, Cuckle H, Musci TJ, Wapner RJ,. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372: 1589-1597.
4. Vora NL, O'Brien BM,. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution. Obstet Gynecol 2014; 123: 1097-1099.
5. Yaron Y, Jani J, Schmid M, Oepkes D,. Current status of testing for microdeletion syndromes and rare autosomal trisomies using cell-free DNA technology. Obstet Gynecol 2015; 126: 1095-1099.
6. Gross SJ, Ryan A, Benn P,. Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive value. Am J Obstet Gynecol 2015; 213: 254-255.
7. Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, Dharajiya N, Monroe TJ, Farkas DH, Grosu DS, McCullough RM,. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015; 35: 999-1004.
8. Taneja P, Curnow K, Halks-Miller M, Seltzer W, de Feo E, Bhatt S,. Noninvasive prenatal screening for microdeletions: Clinical population and outcomes. Prenat Diagn 2015; 35 (Suppl. 1): 15.
9. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, Zhu Z, Lin M, Liu Q, Tian Z, Zhang H, Chen F, Lau TK, Zhao L, Yi X, Yin Y, Wang W,. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies. Ultrasound Obstet Gynecol 2015; 45: 530-538.
10. Friedman N, Rienstein S, Yeshayahu Y, Gothelf D, Somech R., Post-childhood presentation and diagnosis of DiGeorge syndrome. Clin Pediatr (Phila) 2015. pii: 0009922815591090. [Epub ahead of print].
11. Wapner RJ, Babiarz JE, Levy B, Stosic M, Zimmermann B, Sigurjonsson S, Wayham N, Ryan A, Banjevic M, Lacroute P, Hu J, Hall MP, Demko Z, Siddiqui A, Rabinowitz M, Gross SJ, Hill M, Benn P., Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015; 212: 332.e1-9.
12. Yatsenko SA, Peters DG, Saller DN, Chu T, Clemens M, Rajkovic A,. Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med 2015; 17: 836-838.
13. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, Aurias A, Raymond FL, Clayton-Smith J, Hatchwell E, McKeown C, Beemer FA, Dallapiccola B, Novelli G, Hurst JA, Ignatius J, Green AJ, Winter RM, Brueton L, Brøndum-Nielsen K, Scambler PJ,. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34: 798-804.
14. Monteiro FP, Vieira TP, Sgardioli IC, Molck MC, Damiano AP, Souza J, Monlleõ IL, Fontes MI, Fett-Conte AC, Félix TM, Leal GF, Ribeiro EM, Banzato CE, Dantas Cde R, Lopes-Cendes I, Gil-da-Silva-Lopes VL,. Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. Eur J Pediatr 2013; 172: 927-945.
15. Cheung EN, George SR, Andrade DM, Chow EW, Silversides CK, Bassett AS,. Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genet Med 2014; 16: 40-44.
16. Bales AM, Zaleski CA, McPherson EW,. Newborn screening programs: should 22q11 deletion syndrome be added? Genet Med 2010; 12: 135-144.
17. United States Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Response of the Chairperson to the application for 22q11.2 deletion syndrome to be added to newborn screening. 2012. http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/nominatecondition/reviews/deletionsyndrome.pdf [Accessed 22 November 2015].
18. Hui L, Teoh M, da Silva Costa F, Ramsay P, Palma-Dias R, Richmond Z, Piessens S, Walker S,. Clinical implementation of cell-free DNA based aneuploidy screening: perspectives from a national audit. Ultrasound Obstet Gynecol 2015; 45: 10-15.
19. Platt LD, Janicki MB, Prosen T, Goldberg JD, Adashek J, Figueroa R, Rodis J, Liao W, Sehnert AJ, Snyder HL, Warsof SL., Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014; 211: 368.e1-7.
20. Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW,. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 2014; 43: 254-264.
21. Grosse SD, Khoury MJ,. What is the clinical utility of genetic testing? Genet Med 2006; 8: 448-450.
22. Pretto D, Maar D, Yrigollen CM, Regan J, Tassone F,. Screening newborn blood spots for 22q11.2 deletion syndrome using multiplex droplet digital PCR. Clin Chem 2015; 61: 182-190.
23. Grosse SD, McBride CM, Evans JP, Khoury MJ,. Personal utility and genomic information: look before you leap. Genet Med 2009; 11: 575-576.
24. American College of Obstetricians and Gynecologists / Society for Maternal Fetal Medicine Committee Opinion No. 640 2015. Cell-free DNA screening for aneuploidy. https: // www.acog.org/-/media/Committee-Opinions/Committee-on-Genetics/co640.pdf?dmc=1&ts=20151217T1812100812. [Accessed 12 November 2015].
25. Peters D, Chu T, Yatsenko SA, Hendrix N, Hogge WA, Surti U, Bunce K, Dunkel M, Shaw P, Rajkovic A,. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011; 365: 1847-1848.
26. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M,. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012; 58: 1148-1151.
27. Schneider M, Debbané M, Bassett AS, Chow EW, Fung WL, van den Bree M, Owen M, Murphy KC, Niarchou M, Kates WR, Antshel KM, Fremont W, McDonald-McGinn DM, Gur RE, Zackai EH, Vorstman J, Duijff SN, Klaassen PW, Swillen A, Gothelf D, Green T, Weizman A, Van Amelsvoort T, Evers L, Boot E, Shashi V, Hooper SR, Bearden CE, Jalbrzikowski M, Armando M, Vicari S, Murphy DG, Ousley O, Campbell LE, Simon TJ, Eliez S,; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry 2014; 171: 627-639.
28. Shprintzen RJ,. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 2008; 14: 3-10.
29. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM., A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003; 112: 101-107.
30. Devriendt K, Fryns J-P, Mortier G, Van Thienen M-N, Keymolen K,. The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 1998; 35: 789-790.
31. Goodship J, Cross I, LiLing J, Wren C,. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 1998; 79: 348-351.
32. Oskarsdottir S, Vujic M, Fasth A,. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child 2004; 89: 148-151.
33. Tezenas Du Montcel ST, Mendizabal H, Ayme S, Levy A, Philip N,. Prevalence of 22q11 microdeletion. J Med Genet 1996; 33: 719.